DOI:
10.1055/s-00043364
Pharmaceutical Fronts
LinksClose Window
References
Chang J, Ren H, Zhao M. et al.
Development of a series of novel 4-anlinoquinazoline derivatives possessing quinazoline skeleton: design, synthesis, EGFR kinase inhibitory efficacy, and evaluation of anticancer activities in vitro.
Eur J Med Chem 2017;
138: 669-688
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.